Skip to main content
. 2014 May 22;8(2):589–593. doi: 10.3892/ol.2014.2169

Figure 4.

Figure 4

(A) Representive result from the gene sequencing of carcinoma tissue. (B) Cell extracts were prepared from carcinoma tissue and subjected to western blotting or immunoprecipitation using the indicated antibodies. KRASM, a case with the KRAS G12A mutation; BRAFM, a case with the BRAF V600E mutation; PL, primary lung lesion; PM, peritoneal metastasis; IP, immunoprecipitation; IB, immunoblot. The data are representative of three independent experiments.